# OnCo record alliance-oncology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/alliance-oncology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "alliance-oncology" ;
  schema:name "Alliance for Clinical Trials in Oncology"@en ;
  schema:alternateName "Alliance"@en, "Cancer and Leukemia Group B"@en, "CALGB"@en, "Alliance Foundation Trials"@en, "ACOSOG"@en, "NCCTG"@en ;
  schema:description "US cooperative group formed from CALGB, ACOSOG, and NCCTG; running OptimICE-pCR, which asks whether TNBC patients with a complete response still need a year of immunotherapy."@en ;
  schema:url <https://onco.cc/companies/alliance-oncology/>, <https://www.allianceforclinicaltrialsinoncology.org> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Alliance_for_Clinical_Trials_in_Oncology> ;
  owl:sameAs <http://www.wikidata.org/entity/Q4732351> ;
  schema:citation <https://www.allianceforclinicaltrialsinoncology.org> ;
  onco:tag "cooperative-group" ;
  schema:addressCountry "US" ;
  onco:related <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/sentinel-node/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:trials <https://onco.cc/trials/optimice-pcr/>, <https://onco.cc/trials/alliance-n0574/> .